Genetic Disorder L.P. Kkr's Net Worth
Genetic Disorder L.P. Kkr's net worth is estimated to be at least $1,483,034,649.10 as of 06/28/2025. CoreStreet's estimation of Genetic Disorder L.P. Kkr's net worth is based on their sale of stock and current holding of stock.
Genetic Disorder L.P. Kkr is Major Shareholder at KKR & Co LP. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,000,000 units of KKR stock on 05/12/2025. Their biggest sale was on 02/17/2021 when they sold 3,450,000 units of BridgeBio Pharma Inc stock for $208,621,500.00. They typically trade 2 times per year.
Total value of insider buys:
- $90,001,400.00
Total value of insider sells:
- $1,393,033,249.10
Most recent insider trade:
- May 12, 2025
Genetic Disorder L.P. Kkr's Insider Trading History
| KKR & Co LP | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 12, 2025 | Major Shareholder | 6,000,000 | $34.20 | Sell | $205,200,000.00 |
March 5, 2025 | Major Shareholder | 6,000,000 | $32.96 | Sell | $197,760,000.00 |
Sept. 13, 2024 | Major Shareholder | 5,800,000 | $25.75 | Sell | $149,350,000.00 |
July 1, 2019 | Major Shareholder | 2,647,100 | $17.00 | Buy | $45,000,700.00 |
| BridgeBio Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 12, 2025 | Major Shareholder | 6,000,000 | $34.20 | Sell | $205,200,000.00 |
March 5, 2025 | Major Shareholder | 6,000,000 | $32.96 | Sell | $197,760,000.00 |
Sept. 13, 2024 | Major Shareholder | 5,800,000 | $25.75 | Sell | $149,350,000.00 |
Feb. 17, 2021 | Major Shareholder | 3,450,000 | $60.47 | Sell | $208,621,500.00 |
May 28, 2020 | Major Shareholder | 2,389,690 | $33.39 | Sell | $79,791,749.10 |
July 1, 2019 | Major Shareholder | 2,647,100 | $17.00 | Buy | $45,000,700.00 |